API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/an2-therapeutics-pause-lung-disease-study-enrollment-2024-02-12/
https://www.globenewswire.com/news-release/2022/06/29/2471129/0/en/AN2-Therapeutics-Initiates-Pivotal-Phase-2-3-Trial-Evaluating-Epetraborole-for-Treatment-Refractory-MAC-Lung-Disease.html